This scenario parallels the mechanism of the antiproliferative role of DYRK1A in acute myeloid leukemia (AML) cells, where DYRK1A overexpression accelerates c-MYC degradation without affecting mRNA levels [50]. The gene discussed is DYRK1A; the disease is acute myeloid leukemia.